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Abstract.
Background: Duchenne muscular dystrophy (DMD) patients can have various issues that affect their quality of life, including
eating and digestive conditions.
Objective: We sought to identify the relationship between respiratory function and various eating and digestion related
symptoms in patients with advanced Duchenne muscular dystrophy (DMD).
Methods: Eating and digestive symptoms, including loss of appetite, nausea, vomiting, diarrhea, constipation, swallowing
difficulty, mastication difficulty, early satiety, and aspiration, were evaluated among patients with advanced DMD who were
nonambulatory and required noninvasive mechanical ventilatory support. In addition, various respiratory function parameters
were measured, including forced vital capacity (FVC), maximal insufflation capacity (MIC), peak cough flow (PCF), assisted
PCF (APCF), maximal inspiratory pressure (MIP), and maximal expiratory pressure (MEP). We then analyzed the relationship
between gastrointestinal symptoms and respiratory function parameters.
Results: A total of 180 patients (age, 22.3 ± 5.0 years) were included in the analysis. Loss of appetite and early satiety
showed no correlation with any of the respiratory function parameters. Constipation was correlated with MEP; swallowing
difficulty was correlated with MIC, APCF, MIP and MEP; and mastication difficulty was correlated with FVC, PCF, APCF,
MIP, and MEP. Notably, age did not correlate with any gastrointestinal symptoms.
Conclusions: Eating and digestive symptoms are more closely correlated with respiratory function than with age in patients
with DMD. We think this correlation is mainly caused by the skeletal muscle strength, which is major determinant of both
digestive and respiratory function.
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INTRODUCTION
Duchenne muscular dystrophy (DMD), which
affects up to 1 in 3,500 live male births, is an X-
linked recessive, progressive muscular degenerative
disorder [1]. DMD patients show progressive limb
muscle weakness, which leads to a loss of ambula-
tory function in their mid-teens [2]. These patients
also have musculoskeletal deformities such as neuro-
muscular scoliosis and multiple joint contractures [3,
4]. Just a few decades ago, most DMD patients died
in their twenties, and respiratory failure and cardiac
failure were the leading causes of death [5–7]. How-
ever, with improvements in mechanical ventilatory
support and the medical management of cardiomy-
opathy, DMD patients are now living longer than ever
before [8, 9] and several new issues have surfaced that
had not been considered previously [10]. One of these
issues is the development of nutritional conditions
[11]. In a previous study, DMD patients suffering
from gastrointestinal symptoms, such as dysphagia,
choking, heartburn, vomiting, and constipation, were
observed against an age-matched healthy cohort [12].
In patients with muscular disease, nutritional support
and maintenance of proper nutritional status are crit-
ical, given the progressive muscle atrophy and the
increased demand of respiration [13]. However, most
clinicians tend to be less concerned about eating and
digestive symptoms than other complications such as
respiratory and cardiac failure, scoliosis, and osteo-
porosis even with DMD guideline [11] and practical
recommendations [14]. Additionally, there is lack of
research on the correlation between age and phys-
ical functioning with ingestive and gastrointestinal
symptoms in advanced DMD patients. In this study,
we investigated the relationship between various eat-
ing and digestive symptoms and respiratory function
parameters in patients with advanced DMD.
METHODS
Subjects
This retrospective observational study included
subjects diagnosed with DMD by either genetic anal-
ysis or muscle biopsy who were admitted to the
Department of Rehabilitation of a single tertiary uni-
versity hospital between June 2009 and August 2014.
All subjects were nonambulatory and required non-
invasive mechanical ventilatory support.
The following subjects were excluded from the
study: 1) Subjects for whom eating and digestive
symptoms or respiratory function could not be prop-
erly evaluated due to a cognitive deficit. 2) Subjects
who could not tolerate discontinuation of ventila-
tory support for at least 20 minutes, which is the
time required for the respiratory function assessment.
This also resulted in an exclusion of patients who
needed NIV support even during mealtimes. 3) Tra-
cheostomized patients (these were excluded because
the tracheostomy tube interferes with the accurate
measurement of respiratory parameters). 4) Subjects
who could not maintain a sitting position while eat-
ing or who were fed via a gastrostomy or nasogastric
tube.
Evaluation of eating and digestive symptoms
Detailed interviews by experienced dietitians were
used to assess the presence or absence of subjec-
tive eating and digestive symptoms, including loss
of appetite, nausea, vomiting, diarrhea, constipation,
swallowing difficulty, mastication difficulty, early
satiety, and aspiration. Subjects were instructed to
report symptoms that occurred during the 3-month
period prior to the assessment.
Evaluation of respiratory function
The respiratory function of the patients was eval-
uated in various respects. The major respiratory
pathophysiological cause of neuromuscular restric-
tive lung diseases such as DMD, is respiratory muscle
weakness. Because the strength of the respiratory
muscles cannot be evaluated directly, it is assessed
indirectly via measurement of maximal inspiratory
and expiratory pressure. Forced vital capacity (FVC)
is the primary evaluation parameter, as it decreased
in restrictive lung diseases and is a major deter-
minant for deciding whether air-stacking exercises
should be started and predicting hypocapnia. Res-
piratory muscle weakness also decreases coughing
ability, and decreased cough flow makes it difficult
to manage airway secretion and is a major risk factor
for respiratory infection [15]. In accordance with our
previous research, the various respiratory function
parameters that were measured by expert clini-
cians, included FVC, maximum insufflation capacity
(MIC), peak cough flow (PCF), maximal inspira-
tory pressure (MIP), and maximal expiratory pressure
(MEP) [16, 17]. PCF was measured in two differ-
ent ways: unassisted PCF (UPCF) was assessed by
having subjects maximally inhale and then volun-
tarily cough as strongly as possible; assisted PCF
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Table 1
Demographic characteristics of the study group
Average ± standard deviation
(N = 180)
Age 22.3 ± 5.0 years
Height 158.4 ± 8.7 cm
Weight 40.6 ± 15.1 kg
Body mass index 16.3 ± 5.6
Left ventricular ejection fraction (%)† 46.0 ± 15.4
Forced vital capacity (%)†† 619.8 ± 478.4 mL (15.2 ± 12.7%)
Duration of noninvasive ventilation 11.0 ± 4.2 hours/day
Maximal insufflation capacity 1328 ± 532 mL
Unassisted peak cough flow 107 ± 84 L/min
Assisted peak cough flow 258 ± 91 L/min
Maximal inspiratory pressure (%†) 19.4 ± 13.0 cmH2O (19.0 ± 14.6%)
Maximal expiratory pressure (%†) 17.8 ± 10.0 cmH2O (12.0 ± 7.3%)
†Available at 176 patients. ††Ratio for predictive normal value.
(APCF) was assessed with an assistant administer-
ing abdominal thrusts while subjects were in the
MIC state. Percentages of the normal predicted val-
ues were calculated for FVC, MIP, and MEP [18–20].
All respiratory function parameters were measured at
least 3 times, and the maximum values were recorded
and used in the analysis.
Cardiac evaluation
Additionally, we recorded left ventricular ejection
fraction (LVEF), which was evaluated via transtho-
racic echocardiography at the time of assessment of
eating-related symptoms and respiratory function.
Statistical analysis
Statistical analysis was performed using SPSS
ver. 23 (IBM Corp., Armonk, NY, USA). Univariate
logistic regression was used to analyze the relation-
ship between eating/digestive symptoms and various
parameters, including age, pulmonary function, and
LVEF. P < .05 was considered statistically significant.
This study was approved by the Institutional Review
Board of Gangnam Severance Hospital (IRB No. 3-
2015-0335).
RESULTS
A total of 180 subjects were included in this study.
The mean subject age was 22.3 ± 5.0 years (range,
14–40 years). The duration of NIV was 11.0 ± 4.2
hours per day, and in six patients, NIV was discon-
tinued only during mealtime in the day. The LVEF
value was 46.0 ± 15.4%; 4 patients were excluded
from this analysis, because the examinations on these
patients were performed in other hospitals. In total, 87
patients received medications for heart failure at the
time of evaluation. Among the other 93 patients who
did not take the medication, 12 patients were newly
prescribed the medicine and one patient was not able
to take the medicine owing to low blood pressure. The
demographic characteristics of the subjects are shown
in Table 1. Some symptoms, such as nausea, vomit-
ing, diarrhea, and aspiration, were excluded from the
analysis because the incidences of these symptoms
were quite low. For example, only 1 subject had nau-
sea, 2 subjects had aspiration, and none of the subjects
had vomiting or diarrhea.
Loss of appetite and early satiety showed no
correlation with respiratory function. Constipation
was correlated with MEP; swallowing difficulty was
correlated with MIC, APCF, MIP, and MEP; and
mastication difficulty was correlated with FVC, PCF,
APCF, MIP, and MEP. Notably, both age and LVEF
did not correlate with any gastrointestinal symptoms
(Table 2). P values and odds ratios with 95% con-
fidential intervals are shown in Table 2. Multiple
regression analysis was not conducted because all
pulmonary parameters were highly autocorrelated
with one another. For example, MIP and MEP are
associated with FVC, cough flow, and MIC [21–
23]. Moreover, UPCF and APCF are measured when
patients are in the FVC and MIC state, respectively.
DISCUSSION
Eating and digestive symptoms can significantly
affect the quality of life and nutritional status of
patients with advanced DMD. Underlying mecha-
nisms of GI dysfunction in DMD patients are very
intricate and multifactorial. Proposed mechanisms
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include lack of activities; skeletal and smooth muscle
dysfunction; abnormalities of the autonomic ner-
vous system; deformities of body structures, such
as scoliosis, malocclusion, and macroglossia; NIV;
long-term administration of systemic steroids and
calcium; and inadequate diet [11, 24–26]. Pulmonary
function is also determined by various factors such as
respiratory muscle strength, chest wall mobility and
compliance, scoliosis, and bulbar function [15, 27]. In
addition, pulmonary function-related parameters are
measurable and scalable in advanced DMD patients.
Multiple studies have evaluated constipation in
DMD patients and several mechanisms have been
suggested [26, 28, 29]. The function of stool passing
is related to various factors such as psycho-behavioral
factors, posture on defecation, consistency of stool,
dietary contents, age, and sex [30]. The squatting
position increases intra-abdominal pressure during
defecation [31] and permits smooth bowel elimina-
tion through straightening of the recto-anal angle
[32]. Because many DMD patients are unable to
assume the squatting position, they may experi-
ence defecation difficulty. Further, Boland et al. [33]
observed that DMD patients in the second decade
of life develop constipation due to smooth muscle
degeneration in the gastrointestinal tract. It has also
been observed that constipation is closely related to
inadequate fiber and water intake. One of the most
significant observations of the present study is the
relationship between MEP and constipation. Intra-
abdominal pressure, which is required for defecation,
largely depends on abdominal muscle strength, and
abdominal muscle strength is also crucial for gener-
ating MEP.
Swallowing difficulty is another symptom that
affects patients with advanced DMD [34, 35]. It is
a principal cause for decreased oral intake in DMD
patients, even among those who do not experience
aspiration, and closely associated with bulbar muscle
function. MIC and APCF, which are measured when
patients are in the MIC state, are also quite affected by
bulbar function [22]. It is also possible that inspiratory
and expiratory muscle strength, indicated by MIP and
MEP respectively, are associated with bulbar mus-
cle function. Therefore, swallowing function should
be appraised in DMD patients with reduced respira-
tory function in order to ensure adequate nutritional
support and prevent disease progression.
In this study, we also found that mastication dif-
ficulty, which can be caused by weakening of the
muscles of mastication, [36] was related to respira-
tory muscle strength. Symptoms of advanced DMD
include facial muscle weakness, which causes chew-
ing difficulty [37]. Therefore, these patients may
require alternations in food texture even if they have
no difficulty swallowing.
Early satiety is another symptom that affects
patients with advanced DMD and is typically due to
gastroparesis. In 2005, Borrelli et al. [38] observed a
decline in gastric emptying and a higher prevalence of
gastric dysrhythmia in a group of ambulatory DMD
patients below the age of 7 compared with a control
group of healthy children. The researchers suggested
that delayed gastric emptying was caused by DMD
itself since dystrophin is present in smooth muscle
cells, enteric neurons, and interstitial cells of Cajal,
all of which influence gastrointestinal motility. How-
ever, that study showed no correlation between early
satiety and age or between satiety and any of the res-
piratory function parameters included in the present
study.
In this study, we also observed that aspiration
was not prevalent among advanced DMD patients.
That said, even without aspiration, symptoms such as
constipation, swallowing difficulty, mastication diffi-
culty, and early satiety could lead to a decline in oral
intake in these patients. Therefore, advanced DMD
patients should undergo a detailed nutritional evalu-
ation and receive appropriate nutritional support.
Aging of DMD patients is a major determinant of
functional decline, and according to previous studies,
objective findings such as videofluoroscopic swal-
lowing study (VFSS) findings, gastric emptying time,
colon transit time, and electrogastrography findings
were related to patients’ age. However, these studies
failed to reveal abnormalities related to actual asso-
ciated symptoms [29, 39] or did not mention any
symptoms [38]. Although Pane et al. [40] reported
that difficulties in chewing and increase in subse-
quent meal time were increasingly present with age,
and Egli et al. [37] also reported aggravated masti-
cation and orofacial function with age, these studies
included young patients aged under 10 years. The
result that age was not a determinant of GI-related
symptoms in the present study may be caused by
inclusion of patients who were relatively older than
those included in other previous studies. The patients
enrolled in this study were functionally homogenous
(non-ambulatory and supported by NIV).
Some GI symptoms may represent heart failure,
because heart failure can lead to non-specific symp-
toms and signs, including loss of appetite, weight gain
or loss [41]. However, in this study, no eating-related
symptoms were related to LVEF, also.
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To the best of our knowledge, this is the first
study that assessed the correlation between eating and
digestive symptoms and pulmonary function in DMD
patients. We think this correlation is mainly caused by
the skeletal muscle strength, which is one of the major
determinants of various pulmonary function and eat-
ing and digestive symptoms evaluated in the present
study. However, these parameters and symptoms
are determined by very sophisticated mechanisms
and the exact relationship is unclear. Thus, fur-
ther studies, especially those involving adult DMD
patients, are required, because the natural history of
the disease, based on the increased survival rate, is
unclear.
This study has several limitations. First, all subjects
in this study were receiving long-term, NIV support,
which may have caused aerophagia [42]. Aeropha-
gia in turn could have led to various gastrointestinal
symptoms [43]. Second, we assessed the presence
or absence of gastrointestinal symptoms rather than
the severity of symptoms. Third, we did not evalu-
ate any objective parameters reflecting the eating and
digestive disorders, such as colon transit time, nor did
we conduct VFSS. Finally, records regarding patient
medications or interventions such as enemas were
unavailable for this analysis.
In conclusion, eating and digestive symptoms are
more closely correlated with respiratory function than
with age in advanced DMD patients with reduced res-
piratory function. Therefore, these patients should be
carefully evaluated for the presence of gastrointesti-
nal symptoms.
ACKNOWLEDGMENT
This study was not supported by any outside finan-
cial support.
CONFLICT OF INTEREST
The authors have no conflict of interest to report.
REFERENCES
[1] Emery AE. Population frequencies of inherited neuro-
muscular diseases–a world survey. Neuromuscul Disord.
1991;1(1):19-29.
[2] Han JJ, Kilmer DD. Myopathy. In: W.R. Frontera J.A.
DeLisa B.M. Gans N.E. Walsh L.R. Robinson, edi-
tors. DeLisa’s Physical Medicine & Rehabilitation. 5th
ed. Philadelphia: Lippincott Williams & Wilkins. 2010:
757-80.
[3] Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley
R, Florence J, et al. Duchenne muscular dystrophy: Patterns
of clinical progression and effects of supportive therapy.
Neurology. 1989;39(4):475-81.
[4] Johnson ER, Fowler WM, Jr., Lieberman JS. Contrac-
tures in neuromuscular disease. Arch Phys Med Rehabil.
1992;73(9):807-10.
[5] Inkley SR, Oldenburg FC, Vignos PJ, Jr. Pulmonary function
in Duchenne muscular dystrophy related to stage of disease.
Am J Med. 1974;56(3):297-306.
[6] Vignos PJ, Jr. Respiratory function and pulmonary infec-
tion in Duchenne muscular dystrophy. Isr J Med Sci.
1977;13(2):207-14.
[7] Nigro G, Comi LI, Politano L, Bain RJ. The incidence and
evolution of cardiomyopathy in Duchenne muscular dystro-
phy. Int J Cardiol. 1990;26(3):271-77.
[8] Bach JR, Martinez D. Duchenne muscular dystrophy: con-
tinuous noninvasive ventilatory support prolongs survival.
Respir Care. 2011;56(6):744-50.
[9] Ishikawa Y, Miura T, Ishikawa Y, Aoyagi T, Ogata H,
Hamada S, et al. Duchenne muscular dystrophy: Survival
by cardio-respiratory interventions. Neuromuscul Disord.
2011;21(1):47-51.
[10] Parker AE, Robb SA, Chambers J, Davidson AC, Evans K,
O’Dowd J, et al. Analysis of an adult Duchenne muscular
dystrophy population. Qjm. 2005;98(10):729-36.
[11] Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Black-
well A, Brumbaugh D, et al. Diagnosis and management
of Duchenne muscular dystrophy, part 1: Diagnosis,
and neuromuscular, rehabilitation, endocrine, and gas-
trointestinal and nutritional management. Lancet Neurol.
2018;17(3):251-67.
[12] Jaffe KM, McDonald CM, Ingman E, Haas J. Symptoms
of upper gastrointestinal dysfunction in Duchenne muscu-
lar dystrophy: case-control study. Arch Phys Med Rehabil.
1990;71(10):742-44.
[13] Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannac-
cone ST, et al. Respiratory care of the patient with Duchenne
muscular dystrophy: ATS consensus statement. Am J Respir
Crit Care Med. 2004;170(4):456-65.
[14] Toussaint M, Davidson Z, Bouvoie V, Evenepoel N, Haan
J, Soudon P. Dysphagia in Duchenne muscular dystrophy:
practical recommendations to guide management. Disabil
Rehabil. 2016;38(20):2052-62.
[15] Frontera WR, DeLisa JA. Rehabilitation of the patients with
respiratory dysfunction. In: J.R. BachE. Altschuler, editors.
DeLisa’s Physical Medicine and Rehabilitation : Principles
and Practice. 5th ed. Philadelphia: Lippincott Williams &
Wilkins Health; 2010.1099-1023.
[16] Cho HE, Lee JW, Kang SW, Choi WA, Oh H, Lee KC.
Comparison of Pulmonary Functions at Onset of Ventilatory
Insufficiency in Patients With Amyotrophic Lateral Sclero-
sis, Duchenne Muscular Dystrophy, and Myotonic Muscular
Dystrophy. Ann Rehabil Med. 2016;40(1):74-80.
[17] Suh MR, Kim DH, Jung J, Kim B, Lee JW, Choi WA,
et al. Clinical implication of maximal voluntary ventila-
tion in myotonic muscular dystrophy. Medicine (Baltimore).
2019;98(18):e15321.
[18] Morris JF. Spirometry in the evaluation of pulmonary func-
tion. West J Med. 1976;125(2):110-18.
[19] da Costa JL. Pulmonary function studies in healthy Chinese
adults in Singapore. Am Rev Respir Dis. 1971;104(1):128-
31.
[20] Wilson SH, Cooke NT, Edwards RH, Spiro SG. Pre-
dicted normal values for maximal respiratory pressures
J.W. Lee et al. / GI symptoms and respiratory function in DMD patients 107
in caucasian adults and children. Thorax. 1984;39(7):
535-38.
[21] Kang SW, Kang YS, Sohn HS, Park JH, Moon JH. Res-
piratory muscle strength and cough capacity in patients
with Duchenne muscular dystrophy. Yonsei Med J.
2006;47(2):184-90.
[22] Kang SW, Bach JR. Maximum insufflation capacity. Chest.
2000;118(1):61-65.
[23] Deboeck G, Moraine JJ, Naeije R. Respiratory muscle
strength may explain hypoxia-induced decrease in vital
capacity. Med Sci Sports Exerc. 2005;37(5):754-58.
[24] Carron M, Freo U, BaHammam AS, Dellweg D, Guarra-
cino F, Cosentini R, et al. Complications of non-invasive
ventilation techniques: a comprehensive qualitative review
of randomized trials. Br J Anaesth. 2013;110(6):896-914.
[25] Barohn RJ, Levine EJ, Olson JO, Mendell JR. Gastric hypo-
motility in Duchenne’s muscular dystrophy. N Engl J Med.
1988;319(1):15-18.
[26] Kraus D, Wong BL, Horn PS, Kaul A. Constipation in
Duchenne Muscular Dystrophy: Prevalence, Diagnosis, and
Treatment. J Pediatr. 2016;171:183-88.
[27] Mayer OH. Scoliosis and the impact in neuromuscular dis-
ease. Paediatr Respir Rev. 2015;16(1):35-42.
[28] Davis J, Samuels E, Mullins L. Nutrition Considera-
tions in Duchenne Muscular Dystrophy. Nutr Clin Pract.
2015;30(4):511-21.
[29] Lo Cascio CM, Goetze O, Latshang TD, Bluemel S,
Frauenfelder T, Bloch KE. Gastrointestinal Dysfunction in
Patients with Duchenne Muscular Dystrophy. PLoS One.
2016;11(10):e0163779.
[30] Palit S, Lunniss PJ, Scott SM. The physiology of human
defecation. Dig Dis Sci. 2012;57(6):1445-64.
[31] Gerten KA, Richter HE, Wheeler TL, 2nd, Pair LS,
Burgio KL, Redden DT, et al. Intraabdominal pressure
changes associated with lifting: implications for post-
operative activity restrictions. Am J Obstet Gynecol.
2008;198(3):306.e301-305.
[32] Sikirov BA. Primary constipation: an underlying mecha-
nism. Med Hypotheses. 1989;28(2):71-73.
[33] Boland BJ, Silbert PL, Groover RV, Wollan PC, Sil-
verstein MD. Skeletal, cardiac, and smooth muscle
failure in Duchenne muscular dystrophy. Pediatr Neurol.
1996;14(1):7-12.
[34] Willig TN, Paulus J, Lacau Saint Guily J, Beon C, Navarro
J. Swallowing problems in neuromuscular disorders. Arch
Phys Med Rehabil. 1994;75(11):1175-81.
[35] Aloysius A, Born P, Kinali M, Davis T, Pane M, Mercuri
E. Swallowing difficulties in Duchenne muscular dystro-
phy: indications for feeding assessment and outcome of
videofluroscopic swallow studies. Eur J Paediatr Neurol.
2008;12(3):239-45.
[36] van Bruggen HW, Van Den Engel-Hoek L, Steenks MH,
Bronkhorst EM, Creugers NH, de Groot IJ, et al. Reduced
mandibular range of motion in Duchenne Muscular Dystro-
phy: predictive factors. J Oral Rehabil. 2015;42(6):430-38.
[37] Egli F, Botteron S, Morel C, Kiliaridis S. Growing patients
with Duchenne muscular dystrophy: longitudinal changes
in their dentofacial morphology and orofacial functional
capacities. Eur J Orthod. 2018;40(2):140-48.
[38] Borrelli O, Salvia G, Mancini V, Santoro L, Tagliente F,
Romeo EF, et al. Evolution of gastric electrical features
and gastric emptying in children with Duchenne and Becker
muscular dystrophy. Am J Gastroenterol. 2005;100(3):695-
02.
[39] Hanayama K, Liu M, Higuchi Y, Fujiwara T, Tsuji T, Hase
K, et al. Dysphagia in patients with Duchenne muscular
dystrophy evaluated with a questionnaire and videofluorog-
raphy. Disabil Rehabil. 2008;30(7):517-22.
[40] Pane M, Vasta I, Messina S, Sorleti D, Aloysius A, Sciarra
F, et al. Feeding problems and weight gain in Duchenne
muscular dystrophy. Eur J Paediatr Neurol. 2006;10(5-
6):231-36.
[41] Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland
JG, Coats AJ, et al. 2016 ESC Guidelines for the diagno-
sis and treatment of acute and chronic heart failure: The
Task Force for the diagnosis and treatment of acute and
chronic heart failure of the European Society of Cardiol-
ogy (ESC). Developed with the special contribution of the
Heart Failure Association (HFA) of the ESC. Eur J Heart
Fail. 2016;18(8):891-75.
[42] Criner GJ, Brennan K, Travaline JM, Kreimer D. Efficacy
and compliance with noninvasive positive pressure venti-
lation in patients with chronic respiratory failure. Chest.
1999;116(3):667-75.
[43] Fiorentino G, Esquinas AM. Colonic distension treatment
in Duchenne muscular dystrophy. Neuromuscul Disord.
2019;29(2):157-58.
